Julin Yang
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Factors associated with turnover intention among institutional long-term care workers in China: a multi-center cross-sectional study in China.
Journal: Frontiers in public health
Published: March 01, 2026
Dexamethasone synergizes with high-fat diet to increase lipid deposition in adipocytes.
Journal: The Korean journal of internal medicine
Published: January 18, 2024
PPARα suppresses low-intensity-noise-induced body weight gain in mice: the activated HPA axis plays an critical role.
Journal: International journal of obesity (2005)
Published: July 16, 2023
Down-regulation of hepatic CLOCK by PPARα is involved in inhibition of NAFLD.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 24, 2022
Fenofibrate reverses liver fibrosis in cholestatic mice induced by alpha-naphthylisothiocyanate.
Journal: Die Pharmazie
Published: March 14, 2021
PPARα mediates night neon light-induced weight gain: role of lipid homeostasis.
Journal: Theranostics
Published: July 21, 2020
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profile.
Journal: International journal of molecular medicine
Published: November 16, 2019
Cholestatic models induced by lithocholic acid and α‑naphthylisothiocyanate: Different etiological mechanisms for liver injury but shared JNK/STAT3 signaling.
Journal: Molecular medicine reports
Published: October 24, 2019
Therapeutic action against chronic cholestatic liver injury by low-dose fenofibrate involves anti-chemotaxis via JNK-AP1-CCL2/CXCL2 signaling.
Journal: Pharmacological reports : PR
Published: July 21, 2019
PPARα-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling.
Journal: The Journal of pharmacy and pharmacology
Published: July 19, 2018
Last Updated: 09/26/2026